Pharmarun
PrivateLast Round
Pre Seed
Feb 9, 2024
Total Funding Raised
$60,000
Company Overview
Pharmarun is a health-tech company that provides an on-demand platform for medication sourcing, financing, and delivery.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Pharma Supply Chain, Last-Mile Delivery, Telemedicine, BNPL
Business Model
B2B2C
Customer Profile
Marketplace Commission, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmarun Comparables
Compare Pharmarun with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OneHealth | 90% | |
| Famasi | 88% | |
| Advantage Health Africa | 86% |
Pharmarun Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 9, 2024 | ||||
| Grant | Sep 18, 2023 | ||||
| Grant | Jul 11, 2023 |
Key People
Founding team and executive leadership
Pharmarun Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investing in Innovation (i3) Africa | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Grew 20% QoQ, from 35 to 42 employees.
- Oct 14, 2025
Grew 16% QoQ, from 32 to 37 employees.
Pharmarun Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pharmarun's valuation, stock price, and market status.
Is Pharmarun a public or private company?
Pharmarun is a private company.
What is the current stock price of Pharmarun?
Pharmarun is a private company, so its shares have no public market price. Caplight tracks Pharmarun's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharmarun worth (valuation)?
Valuation information for Pharmarun is not publicly available.
Can I buy Pharmarun stock?
Pharmarun shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharmarun's last funding round?
Pharmarun's most recent funding round was Pre Seed on February 9, 2024.
Who are the main investors in Pharmarun?
Key investors in Pharmarun include Investing in Innovation (i3) Africa.
Will Pharmarun IPO soon?
No public IPO plans have been announced for Pharmarun.
How can I track Pharmarun secondary market activity?
Caplight tracks bids, offers, and trades in Pharmarun's shares on secondary markets.